17.1 A RANDOMIZED CONTROLLED TRIAL OF CANNABIDIOL IN SCHIZOPHRENIA

BACKGROUND: Both preclinical and human research suggest that cannabidiol (CBD) has antipsychotic properties. This study assessed the safety and effectiveness of CBD in patients with schizophrenia. METHODS: Patients with schizophrenia (n=88) were randomized to receive CBD (1000 mg/day) or placebo alo...

全面介紹

Na minha lista:
書目詳細資料
發表在:Schizophr Bull
Main Authors: McGuire, Philip, Robson, Philip, Cubała, Wiesław, Vasile, Daniel, Morrison, Paul, Barron, Rachel, Taylor, Adam, Wright, Stephen
格式: Artigo
語言:Inglês
出版: Oxford University Press 2018
主題:
Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5887970/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby014.065
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍